Bioharvest sciences to participate in noble capital markets emerging growth conference on december 3, 2024

Vancouver, british columbia and rehovot, israel--(newsfile corp. - november 21, 2024) - bioharvest sciences inc. (nasdaq: bhst) (cse: bhsc) (fse: 8mv0) ("bioharvest" or the "company"), a company pioneering its patented botanical synthesis technology platform, today announced that management has been invited to attend the noble capital markets 20th annual emerging growth equity conference taking place on december 3, 2024. ceo ilan sobel is scheduled to host one-on-one meetings with institutional investors throughout the event and will host a presentation for in-person attendees.
NE Ratings Summary
NE Quant Ranking